Welcome to our dedicated page for Vera Bradley SEC filings (Ticker: VRA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Vera Bradley's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Vera Bradley's regulatory disclosures and financial reporting.
Vera Bradley, Inc. entered into Executive Severance Plan Agreements on July 24, 2026 with Chief Operating and Financial Officer Martin Layding and Chief Brand Officer Melinda Paraie.
For a termination by the company without Cause or by the executive for Good Reason, each would be entitled to a lump-sum payment equal to twelve (12) months of then-current base salary, any earned but unpaid annual bonus for the prior fiscal year, and, if termination occurs after the first fiscal quarter, a pro rata portion of the annual bonus for the year of termination. They would also receive payment of up to twelve (12) months of COBRA health insurance premiums if elected, immediate vesting of any unvested sign-on restricted stock units, and pro-rated vesting of other unvested restricted stock units granted on or before January 31, 2028, subject to applicable performance vesting targets.
If such a termination occurs within six (6) months prior to or 24 months after a Change in Control, each executive would receive an additional amount equal to six (6) months of base salary. Receipt of benefits is conditioned on compliance with non-competition, non-solicitation, confidentiality, and non-disparagement covenants. The company will reimburse up to $5,000 of Mr. Layding’s legal fees related to his agreement.
Vera Bradley, Inc. Chief Executive Officer Ian Bickley reported a routine tax-related share disposition. On the reported date, 30,273 Common Shares were withheld at $3.91 per share to cover tax obligations tied to the vesting of a previously granted restricted stock unit award.
After this tax-withholding event, Bickley directly owned 1,058,337 Common Shares. He also had an additional 135,623 Common Shares held indirectly through the Ian Bickley Revocable Trust, for which he and his wife serve as trustees and he is the sole beneficiary.
Vera Bradley, Inc. chief administrative officer Mark C. Dely reported a routine tax-related share disposition. On the vesting of a previously granted restricted stock unit award, 13,709 shares of common stock were withheld to satisfy tax withholding obligations. These are not open-market sales. After this withholding, Dely directly holds 343,362 Vera Bradley shares, indicating he retains a substantial equity position in the company.
Vera Bradley, Inc. Chief Executive Officer Ian Bickley reported an open-market purchase of common shares. An entity associated with him, the Ian Bickley Revocable Trust, bought 28,901 common shares at a weighted-average price of $3.87 per share, with individual trades ranging from $3.44 to $4.27. Following this purchase, the trust holds 135,623 common shares indirectly. A separate holding entry shows Bickley with 1,088,610 common shares held directly. The filing also clarifies that prior Forms 4 during April 8, 2025 to April 7, 2026 had incorrectly shown certain shares as directly owned; these are actually held indirectly in the revocable trust, for which Bickley and his wife serve as trustees, and he disclaims beneficial ownership except to the extent of his pecuniary interest.
Vera Bradley, Inc. Chief Financial Officer Martin Layding reported routine share dispositions related to tax withholding on vested equity awards. On June 12, 2026, a total of 43,365 shares of common stock were withheld in two transactions at $3.46 per share to cover tax obligations from a previously granted restricted stock unit award, rather than sold in the open market. After these transactions, he directly owns 459,570 shares of common stock and an additional 250 shares held indirectly through the Layding Family Trust.
Vera Bradley, Inc. director Andrew Meslow bought additional company stock in the open market. On June 12, 2026, he purchased 24,926 Common Shares at a price of $3.73 per share in an open-market transaction. Following this purchase, he directly owns 650,000 Common Shares.
Vera Bradley, Inc. reported a much smaller loss while returning to growth in its latest quarter. Net revenues rose to $55.7 million from $51.7 million, driven by a 13.4% increase in comparable sales and stronger Indirect segment demand.
Gross margin expanded to 51.8% from 44.1% as freight and duty costs eased and prior-year charges did not recur. Selling, general, and administrative expenses fell 16.4% to $34.1 million, reflecting cost optimization, lower advertising, and store expense reductions.
Operating loss from continuing operations improved to $(4.6) million from $(17.9) million, and net loss from continuing operations narrowed to $(4.8) million. The company ended the quarter with $12.5 million in cash and no borrowings under its $75 million credit facility, with $68.0 million of availability.
Vera Bradley, Inc. reported a solid turnaround in its first quarter of Fiscal 2027. Consolidated net revenues from continuing operations rose 7.8% to $55.7 million from $51.7 million, marking the first quarter of growth since Fiscal 2022.
Net loss from continuing operations narrowed sharply to $(4.8) million, or $(0.17) per diluted share, from $(18.3) million, or $(0.66) per share. On a non-GAAP basis, net loss improved to $(2.5) million from $(10.1) million. Gross profit increased to $28.8 million, with gross margin expanding to 51.8% versus 44.1% (47.5% non-GAAP) a year ago, while SG&A fell to $34.1 million from $40.8 million.
Operating loss from continuing operations improved to $(4.6) million, or (8.3%) of net revenues, versus $(17.9) million, or (34.6%), a 74% reduction; non-GAAP operating loss fell 76.1% to $(3.3) million. Direct segment revenues grew 4.1% to $44.9 million with 13.4% comparable sales growth, and Indirect revenues climbed 26.6% to $10.8 million.
Inventory declined 26% to $73.0 million, the leanest first-quarter level since fiscal 2011, and cash and cash equivalents were $12.5 million with no ABL borrowings. For Fiscal 2027, the Company guides sales of $255–$270 million and expects non-GAAP operating loss improvement of at least 50% versus the prior year loss of $(21.7) million.
Vera Bradley, Inc. chief administrative officer Mark C. Dely reported routine equity compensation and tax-related share dispositions. On 2026-06-08, he received 9,110 shares of common stock as an earned performance share award, settled in shares of common stock. To cover tax withholding obligations tied to the vesting of a previously granted restricted stock unit award, the company withheld a total of 3,919 shares of common stock at $3.08 per share through two separate tax-withholding dispositions. After these transactions, Dely directly held 357,071 shares of Vera Bradley common stock.
Vera Bradley, Inc. held its 2026 Annual Meeting of Shareholders on June 4, 2026, where all management proposals were approved. Shareholders elected six directors to one-year terms and ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending January 30, 2027.
On an advisory basis, shareholders approved the compensation of the company’s named executive officers, with 13,401,721 votes for and 3,889,590 against. Shareholders also approved an amendment to the 2020 Equity and Incentive Plan to add an additional 3,000,000 shares of common stock, with 11,501,853 votes for, 5,157,094 against, and 661,647 abstentions.